Formation and uptake of arylhydroxylamine-haptenated proteins in human dendritic cells.
Bioactivation of sulfonamides and the subsequent formation of haptenated proteins is believed to be a critical step in the development of hypersensitivity reactions to these drugs. Numerous lines of evidence suggest that the presence of such adducts in dendritic cells (DCs) migrating to draining lymph nodes is essential for the development of cutaneous reactions to xenobiotics. Our objective was to determine the ability of human DCs to form drug-protein covalent adducts when exposed to sulfamethoxazole (SMX), dapsone (DDS), or their arylhydroxylamine metabolites [sulfamethoxazole hydroxylamine (S-NOH) and dapsone hydroxylamine (D-NOH)] and to take up preformed adduct. Naive and immature CD34+ KG-1 cells were incubated with SMX, DDS, or metabolites. Formation of haptenated proteins was probed using confocal microscopy and ELISA. Cells were also incubated with preformed adduct (drug-bovine serum albumin conjugate), and uptake was determined using confocal microscopy. Both naive and immature KG-1 cells were able to bioactivate DDS, forming drug-protein adducts, whereas cells showed very little protein haptenation when exposed to SMX. Exposure to S-NOH or D-NOH resulted in protein haptenation in both cell types. Both immature and naive KG-1 cells were able to take up preformed haptenated proteins. Thus, DCs may acquire haptenated proteins associated with drugs via intracellular bioactivation, uptake of reactive metabolites, or uptake of adduct formed and released by adjacent cells (e.g., keratinocytes).
Roychowdhury
Sanjoy
S
Office of the Dean, College of Pharmacy, Nursing and Health Sciences, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 49707, USA.
Vyas
Piyush M
PM
Svensson
Craig K
CK
D001692:Biological Transport; D001711:Biotransformation; D002454:Cell Differentiation; D002460:Cell Line; D003622:Dapsone / Q000031:analogs & derivatives* / Q000378:metabolism; D003713:Dendritic Cells / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D006241:Haptens / Q000378:metabolism*; D006801:Humans; D018613:Microscopy, Confocal; D010105:Oxygenases / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D011485:Protein Binding; D011506:Proteins / Q000378:metabolism*; D012710:Serum Albumin, Bovine / Q000378:metabolism; D013420:Sulfamethoxazole / Q000031:analogs & derivatives* / Q000378:metabolism; D013997:Time Factors
D006241:Haptens; D011506:Proteins; C059873:sulfamethoxazole hydroxylamine; D012710:Serum Albumin, Bovine; D003622:Dapsone; D009195:Peroxidase; D010105:Oxygenases; C020066:dimethylaniline monooxygenase (N-oxide forming); C018209:4-amino-4'-hydroxylaminodiphenylsulfone; D013420:Sulfamethoxazole